Efficacy and Safety of Panax ginseng Sprout Extract in Subjective Memory Impairment: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

Hyang-Im Baek,Ki-Chan Ha,Yu-Kyung Park,Tae-Young Kim,Soo-Jung Park
DOI: https://doi.org/10.3390/nu16121952
IF: 5.9
2024-06-20
Nutrients
Abstract:Sprout ginseng extract (ThinkGINTM) manufactured through a smart farm system has been shown to improve memory in preclinical studies. This study conducted a 12-week randomized, double-blind, placebo-controlled clinical trial to evaluate the efficacy and safety of ThinkGINTM for improving memory in subjective memory impairment (SMI). Subjects aged 55 to 75 years with SMI participated in this study. A total of 80 subjects who met the inclusion/exclusion criteria were assigned to the ThinkGINTM group (n = 40, 450 mg ThinkGINTM/day) or a placebo group (n = 40). Efficacy and safety evaluations were conducted before intervention and at 12 weeks after intervention. As a result of 12 weeks of ThinkGINTM intake, significant differences in SVLT, RCFT, MoCA-K, PSQI-K, and AChE were observed between the two groups. Safety evaluation (AEs, laboratory tests, vital signs, and electrocardiogram) revealed that ThinkGINTM was safe with no clinically significant changes. Therefore, ThinkGINTM has the potential to be used as a functional food to improve memory.
nutrition & dietetics
What problem does this paper attempt to address?